CV Sciences Inc (OTCMKTS:CVSI) is pleased about the recent success in the roll-out of more Vitamin Shoppe locations. The company has been targeting to expand the reach of its diverse products to more consumers. Initially, the company had unveiled about 400 The Vitamin Shoppe locations, and the latest addition takes the number to a total of 515 locations. These stores are located in 36 U.S. states and Puerto Rico, and the company says it will continue making more efforts.
The Chief Executive Officer of CV Sciences Joseph Dowling has made his statement regarding the recent developments. This company official says that they have come across many challenges, but he is glad they are moving forward in spite of that.
He adds that the delivery of high-quality products is their greatest drive and that they are not going to make any compromises on that. CV Sciences’ efficacious CBD hemp extract products are about the promotion of healthy lifestyles among consumers.
A close outlook at the company’s business activities
The product distribution is being done across a vast assortment of CV Sciences’ best-selling PlusCBD™ Oil products. Some of the products under sale include the company’s topical products, such as PlusCBD™ Oil Roll-On and the PlusCBD™ Oil Extra Strength Balm.
This PlusCBD™ Oil Roll-On was unveiled just a short while back. The company also seeks to boost the sale of its PlusCBD™ Oil full-spectrum hemp extracts, including Gold Formula Drops, Gold Formula Softgels, and Total Plant Complex Sprays and Capsules.
PlusCBD™ Oil is known to perform remarkably in the Total U.S. Natural Channel, having the best-selling CBD hemp extract supplement. Its Extra Strength Balm is a top-rated product according to results from researchers SPINS and IRI data*. The research bodies indicate the products performing well in the Total U.S. MULO (Multi-Outlet) and the Total U.S. Natural Channel.
CV Sciences is proud to have its product hitting such high-performance levels among the hemp CBD topical this year. Reports show an annual growth rate of almost 169%, and this is for the period 2018 – 2022.
In its recent statement, CV Sciences said it was going to channel more funds in both its distinct business segments. These are the consumer product division and drug development division. It will be seeking to boost their operations for increased revenues.
Generex Biotechnology Corporation (OTCMKTS:GNBT) Submits Pre-IND For Ii-Key-SARS-CoV-2 Vaccine To The FDA
Post Views: 124 Generex Biotechnology Corporation (OTCMKTS:GNBT) submitted a Pre-IND update to the FDA outlining its proposed Phase I/II clinical...
cbdMD Inc. (NYSEAMERICAN:YCBD) Protecting Its CBD Technologies Through Patents and expands Partnership With Bellator MMA
Post Views: 283 cbdMD Inc. (NYSEAMERICAN:YCBD) announced an extension of the exclusive Official CBD marketing partnership with ViacomCBS’s wholly-owned subsidiary...
CLS Holdings USA Inc (OTCMKTS:CLSH) Increases Revenues In June 2020 By 5.35%
Post Views: 185 CLS Holdings USA Inc (OTCMKTS:CLSH) posted a growth of 5.35% YoY to $1.102 million in June 2020....
Canopy Rivers Inc.’s (OTCMKTS:CNPOF) Portfolio Companies Expanding Their Reach In Canada And The US
Post Views: 239 Canopy Rivers Inc.’s (OTCMKTS:CNPOF) three portfolio companies recently announced plans to expand their product offering for recreational...
AgraFlora Organics International Inc. (OTCMKTS:AGFAF) Processes Around 1,000KG Of CBD Crude Oil From 10,000Kg Of Hemp
Post Views: 304 AgraFlora Organics International Inc. (OTCMKTS:AGFAF) Toronto-based Sustainable Growth Strategic Capital Corp subsidiary in partnership with MicroC45 produced...
Marimed Inc (OTCMKTS:MRMD) Retires $7.3 Million Short-term Debt: Robust Sales Of Adult-Use Programs Improves Cash Flow
Post Views: 171 Marimed Inc (OTCMKTS:MRMD) restructured its debt to provide financial flexibility at reduced interest rates. Marimed replaced the...